AGAnastasiia A. Galkina

Anastasiia A. Galkina

*This is an algorithmically generated author record based on publicly available information.

Anastasiia A. Galkina has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Evaluation of the immunomodulatory potential of humic substances and chitosan fractions and their effect on melanoma metastasis

    by D.S. Gorshenin, Yu.V. Zhernov, V.E. Tikhonov, A.A. Galkina, D.K. Bolyakina, V.A. Parshina, G.O. Gudima, M.R. Khaitov

  • Preclinical study of reproductive toxicity of a drug based on an aqueous solution of fullerene С60 for the treatment of food allergies

    by Elena V. Kovaleva, Yulia V. Ivanova, Nikolay M. Onatsky, Vitaliia A. Shangaraeva, Denis S. Gorshenin, Elena N. Baraboshkina, Anastasiia A. Galkina, Darya K. Bolyakina, Veronika A. Parshina, Renata A. Kurmasheva, et al.

    BACKGROUND: The incidence of food allergy in adults and children is very high. The key approach in the therapy of food allergy can be quality drug selection. New synthetic derivatives of fullerene, a high-tech hydrocarbon, can become such drugs. A unique biocompatible method for obtaining a stable aqueous dispersion of fullerene C60 (ADF-C60) as the main component for drugs for the treatment of allergic diseases has been developed. In this article, reproductive toxicity of the drug ADF-C60, currently in preclinical safety studies, was studied in female white outbred rats. Due to its properties, the ADF-C60 is promising for treatment of food allergy and can presumably be used during pregnancy. AIM: Preclinical study of reproductive toxicity of an ADF-C60 in the antenatal and postnatal periods of rat offspring development with oral administration to the mother generation during pregnancy. MATERIALS AND METHODS: Female rats were orally administered the ADF-C60 in 1-, 5-, and 50-fold therapeutic doses recommended for humans during the whole pregnancy. The general parameters of embryotoxic and teratogenic effects of the ADF-C60 before and after birth were studied. RESULTS: No evidence of embryotoxic and teratogenic effects of the ADF-C60 was found during the study of gestational parameters and general fetuses development. No adverse effects of the ADF-C60 were revealed during observation of postnatal development of offspring. CONCLUSION: ADF-C60 for the treatment of food allergy has no reproductive toxicity at doses up to 50 times higher than the therapeutic dose. After the conducted experiments it is possible to assume a significant probability of using the ADF-C60 during pregnancy, but additional preclinical and clinical studies are required to substantiate the obtained conclusion.


  • Open Access

    Development of wound healing drugs based on antibacterial cationic peptides and fullerene C60

    by A.A. Galkina, N.N. Shershakova, M.V. Khodzhava, D.K. Bolyakina, A.K. Golomidova, O.O. Koloskova, D.S. Gorshenin, S.M. Andreev, G.O. Gudima, D.A. Kudlay, et al.

    Создание ранозаживляющих препаратов на основе антибактериальных катионных пептидов и фуллерена C60


  • Cationic peptides as promising compounds for the treatment of bacterial complications in atopic dermatitis: Antibacterial activity assessment

    by Anastasia A. Galkina, Darya K. Bolyakina, Anastasia V. Shatilova, Marina O. Babikhina, Alla K. Golomidova, Alexandra A. Nikonova, Sergey M. Andreev, Dmitry A. Kudlay, Nadezda N. Shershakova, Musa R. Khaitov, et al.

    BACKGROUND: The decrease in the effectiveness of antibiotics against the background of resistance of microorganisms aggravates the therapy of atopic dermatitis complicated by bacterial infection and actualizes the development of new antimicrobial agents. AIM: To develop, synthesize, and evaluate the antibacterial activity of cationic peptides and an aqueous solution of fullerene C60 to create drugs based on them that will have a spectrum of biological activity, including anti-inflammatory, antiallergic, and antibacterial activities. MATERIALS AND METHODS: This study analyzed the developed linear and dendrimer cationic peptides, whose structure was confirmed by matrix-assisted laser desorption ionization–time of flight mass spectrometry. An aqueous solution of fullerene C60 was obtained using a uniquely developed and patented technology. Antibacterial activity was assessed by diffusion into agar using disks (screening) and serial dilution, which was used to determine the minimum bactericidal concentration of the studied compounds. RESULTS: Moreover, 42 cationic peptides with various structures were developed and synthesized. The molecular weight of the peptides did not exceed 5,000 Da. They contained 7–25 amino acids with charges from +5 to +16. Screening was carried out through diffusion into agar using disks and revealed 15 peptides that showed activity against Escherichia coli Dh5a. Thus, using the method of counting colonies, the peptides AB-14, AB-17, and AB-18 showed bactericidal activity relative to E. coli Dh5a in concentrations of 0.03, 0.15, and 0.74 mM, respectively, which exceeded that of ampicillin (0.74 mM) several times. Analysis of an aqueous solution of fullerene C60 did not reveal its antibacterial activity. CONCLUSIONS: The antibacterial activity of the resulting peptides makes them promising for the development of antibacterial therapeutic agents.